Genmab

genmab.com

Genmab is a leading international biotechnology company focused on pioneering antibody science to improve the lives of patients with cancer and other serious diseases. The company develops innovative antibody-based products through proprietary technologies, with around 20 compounds in clinical development and 8 approved medicines. Genmab's commitment to sustainability and collaboration with healthcare professionals and industry partners positions it as a key player in the biotechnology sector, aiming to address unmet medical needs and make a lasting impact on patient care.